Jain Global’s Pfizer PFE Stock Holding History

Jain Global’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-77,907	Closed	-$2.19M	–	1973
2026 Q1	$2.19M	Sell	77,907 -67,382	-46%	-$1.79M	0.01%	667
2025 Q4	$3.62M	Sell	145,289 -257,311	-64%	-$6.49M	0.02%	476
2025 Q3	$10.3M	Buy	402,600 +98,303	+32%	+$2.43M	0.05%	228
2025 Q2	$7.38M	Sell	304,297 -337,067	-53%	-$7.86M	0.06%	266
2025 Q1	$16.3M	Buy	+641,364	New	+$16.8M	0.19%	85

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Jain Global's PFE Position: Q2 2026 in Review

Jain Global sold out of Pfizer (PFE) in Q2 2026, closing a stake of 77,907 shares — an estimated $2.19M sold.

Jain Global first reported a position in PFE in Q1 2025 and held it in 5 quarters. The position peaked at $16.3M in Q1 2025. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Jain Global reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
Jain Global sold 77,907 Pfizer shares in Q2 2026, an estimated $2.19M.
Jain Global first reported a position in Pfizer in Q1 2025 and held it in 5 quarters.
Jain Global's Pfizer position peaked at $16.3M in Q1 2025.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.